Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 30

Related Articles by Review for PubMed (Select 22193376)

1.

Mild cognitive impairment in Parkinson's disease.

Goldman JG, Litvan I.

Minerva Med. 2011 Dec;102(6):441-59. Review.

2.

[Mild cognitive impairment in Parkinson's disease].

Wada K, Nakashima K.

Brain Nerve. 2012 Dec;64(12):1365-75. Review. Japanese.

PMID:
23209063
3.

Mild cognitive impairment in Parkinson disease: heterogenous mechanisms.

Jellinger KA.

J Neural Transm. 2013 Jan;120(1):157-67. doi: 10.1007/s00702-012-0771-5. Epub 2012 Feb 18. Review.

PMID:
22350538
4.

MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI.

Litvan I, Aarsland D, Adler CH, Goldman JG, Kulisevsky J, Mollenhauer B, Rodriguez-Oroz MC, Tröster AI, Weintraub D.

Mov Disord. 2011 Aug 15;26(10):1814-24. doi: 10.1002/mds.23823. Epub 2011 Jun 9. Review.

5.

Mild cognitive impairment in Parkinson's disease.

Yarnall AJ, Rochester L, Burn DJ.

Age Ageing. 2013 Sep;42(5):567-76. doi: 10.1093/ageing/aft085. Epub 2013 Jul 17. Review.

6.

[Cognitive impairment in Parkinson's disease].

Tachibana H.

Seishin Shinkeigaku Zasshi. 2013;115(11):1142-9. Review. Japanese.

PMID:
24450147
7.

Mild cognitive impairment exists in Parkinson's disease.

Rektorova I.

J Neural Transm. 2011 Aug;118(8):1179-83. doi: 10.1007/s00702-011-0674-x. Epub 2011 Jun 19. Review.

PMID:
21688112
8.

Parkinson's disease mild cognitive impairment: application and validation of the criteria.

Geurtsen GJ, Hoogland J, Goldman JG, Schmand BA, Tröster AI, Burn DJ, Litvan I; MDS Study Group on the Validation of PD-MCI Criteria.

J Parkinsons Dis. 2014;4(2):131-7. doi: 10.3233/JPD-130304. Review.

9.

A précis of recent advances in the neuropsychology of mild cognitive impairment(s) in Parkinson's disease and a proposal of preliminary research criteria.

Tröster AI.

J Int Neuropsychol Soc. 2011 May;17(3):393-406. doi: 10.1017/S1355617711000257. Review.

PMID:
21473805
10.

Mild cognitive impairment in Parkinson's disease.

Aarsland D, Brønnick K, Fladby T.

Curr Neurol Neurosci Rep. 2011 Aug;11(4):371-8. doi: 10.1007/s11910-011-0203-1. Review.

PMID:
21487730
11.

Is all cognitive impairment in Parkinson's disease "mild cognitive impairment"?

Martínez-Horta S, Kulisevsky J.

J Neural Transm. 2011 Aug;118(8):1185-90. doi: 10.1007/s00702-011-0675-9. Epub 2011 Jun 22. Review.

PMID:
21695418
12.

Mild cognitive impairment and cognitive reserve in Parkinson's disease.

Poletti M, Emre M, Bonuccelli U.

Parkinsonism Relat Disord. 2011 Sep;17(8):579-86. doi: 10.1016/j.parkreldis.2011.03.013. Epub 2011 Apr 12. Review.

PMID:
21489852
13.

Neurobiology of cognitive impairment in Parkinson's disease.

Jellinger KA.

Expert Rev Neurother. 2012 Dec;12(12):1451-66. doi: 10.1586/ern.12.131. Review.

PMID:
23237352
14.

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines.

Litvan I, Goldman JG, Tröster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH, Aarsland D, Kulisevsky J, Rodriguez-Oroz MC, Burn DJ, Barker RA, Emre M.

Mov Disord. 2012 Mar;27(3):349-56. doi: 10.1002/mds.24893. Epub 2012 Jan 24. Review.

15.
16.

Neuroimaging of brain changes associated with cognitive impairment in Parkinson's disease.

Christopher L, Strafella AP.

J Neuropsychol. 2013 Sep;7(2):225-40. doi: 10.1111/jnp.12015. Epub 2013 Apr 1. Review.

17.

Radionuclide brain imaging correlates of cognitive impairment in Parkinson's disease (PD).

Nobili F, Morbelli S, Arnaldi D, Ferrara M, Campus C, Brugnolo A, Mazzei D, Mehrdad N, Sambuceti G, Rodriguez G.

J Neurol Sci. 2011 Nov 15;310(1-2):31-5. doi: 10.1016/j.jns.2011.06.053. Epub 2011 Jul 16. Review.

PMID:
21762928
18.

Cognitive impairment in nondemented Parkinson's disease.

Barone P, Aarsland D, Burn D, Emre M, Kulisevsky J, Weintraub D.

Mov Disord. 2011 Dec;26(14):2483-95. doi: 10.1002/mds.23919. Epub 2011 Aug 24. Review.

PMID:
22170275
19.

Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.

Rolinski M, Fox C, Maidment I, McShane R.

Cochrane Database Syst Rev. 2012 Mar 14;3:CD006504. doi: 10.1002/14651858.CD006504.pub2. Review.

PMID:
22419314
20.

Magnetic resonance imaging: a biomarker for cognitive impairment in Parkinson's disease?

Duncan GW, Firbank MJ, O'Brien JT, Burn DJ.

Mov Disord. 2013 Apr;28(4):425-38. doi: 10.1002/mds.25352. Epub 2013 Feb 28. Review.

PMID:
23450518
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk